Home Healthcare Biotechnology Infectious Respiratory Disease Diagnostics Market

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables, Services), By Sample Type (Saliva, Nasopharyngeal Swabs (NPS), Anterior Nasal Swabs, Blood, Others), By Technology (Immunoassay, Molecular Diagnostics, Microbiology, Other technologies), By Application (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Tuberculosis, Streptococcus Testing, Other Respiratory Disease Testing), By End-Use (Hospitals, Diagnostic Laboratories, Physician Offices, Other End Users) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR5230DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Infectious Respiratory Disease Diagnostics Market, By Product Type 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Consumables
    3. Services
  2. Infectious Respiratory Disease Diagnostics Market, By Sample Type 2022-2034 (USD MILLION/ Units)
    1. Saliva
    2. Nasopharyngeal Swabs (NPS)
    3. Anterior Nasal Swabs
    4. Blood
    5. Others
  3. Infectious Respiratory Disease Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Immunoassay
    2. Molecular Diagnostics
    3. Microbiology
    4. Other technologies
  4. Infectious Respiratory Disease Diagnostics Market, By Application 2022-2034 (USD MILLION/ Units)
    1. COVID-19
    2. Influenza
    3. Respiratory Syncytial Virus (RSV)
    4. Tuberculosis
    5. Streptococcus Testing
    6. Other Respiratory Disease Testing
  5. Infectious Respiratory Disease Diagnostics Market, By End-Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Laboratories
    3. Physician Offices
    4. Other End Users
  6. Regional Infectious Respiratory Disease Diagnostics Market
    1. North America
      1. North America Infectious Respiratory Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Services
      2. North America Infectious Respiratory Disease Diagnostics Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Saliva
        2. Nasopharyngeal Swabs (NPS)
        3. Anterior Nasal Swabs
        4. Blood
        5. Others
      3. North America Infectious Respiratory Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Microbiology
        4. Other technologies
      4. North America Infectious Respiratory Disease Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. COVID-19
        2. Influenza
        3. Respiratory Syncytial Virus (RSV)
        4. Tuberculosis
        5. Streptococcus Testing
        6. Other Respiratory Disease Testing
      5. North America Infectious Respiratory Disease Diagnostics Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Physician Offices
        4. Other End Users
      6. U.S.
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      7. Canada
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
    2. Europe
      1. Europe Infectious Respiratory Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Services
      2. Europe Infectious Respiratory Disease Diagnostics Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Saliva
        2. Nasopharyngeal Swabs (NPS)
        3. Anterior Nasal Swabs
        4. Blood
        5. Others
      3. Europe Infectious Respiratory Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Microbiology
        4. Other technologies
      4. Europe Infectious Respiratory Disease Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. COVID-19
        2. Influenza
        3. Respiratory Syncytial Virus (RSV)
        4. Tuberculosis
        5. Streptococcus Testing
        6. Other Respiratory Disease Testing
      5. Europe Infectious Respiratory Disease Diagnostics Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Physician Offices
        4. Other End Users
      6. U.K.
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      7. Germany
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      8. France
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      9. Spain
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      10. Italy
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      11. Russia
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      12. Nordic
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      13. Benelux
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      14. Rest of Europe
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
    3. APAC
      1. APAC Infectious Respiratory Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Services
      2. APAC Infectious Respiratory Disease Diagnostics Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Saliva
        2. Nasopharyngeal Swabs (NPS)
        3. Anterior Nasal Swabs
        4. Blood
        5. Others
      3. APAC Infectious Respiratory Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Microbiology
        4. Other technologies
      4. APAC Infectious Respiratory Disease Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. COVID-19
        2. Influenza
        3. Respiratory Syncytial Virus (RSV)
        4. Tuberculosis
        5. Streptococcus Testing
        6. Other Respiratory Disease Testing
      5. APAC Infectious Respiratory Disease Diagnostics Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Physician Offices
        4. Other End Users
      6. China
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      7. Korea
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      8. Japan
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      9. India
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      10. Australia
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      11. Singapore
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      12. Taiwan
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      13. South East Asia
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      14. Rest of Asia-Pacific
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
    4. Middle East and Africa
      1. Middle East and Africa Infectious Respiratory Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Services
      2. Middle East and Africa Infectious Respiratory Disease Diagnostics Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Saliva
        2. Nasopharyngeal Swabs (NPS)
        3. Anterior Nasal Swabs
        4. Blood
        5. Others
      3. Middle East and Africa Infectious Respiratory Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Microbiology
        4. Other technologies
      4. Middle East and Africa Infectious Respiratory Disease Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. COVID-19
        2. Influenza
        3. Respiratory Syncytial Virus (RSV)
        4. Tuberculosis
        5. Streptococcus Testing
        6. Other Respiratory Disease Testing
      5. Middle East and Africa Infectious Respiratory Disease Diagnostics Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Physician Offices
        4. Other End Users
      6. UAE
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      7. Turkey
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      8. Saudi Arabia
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      9. South Africa
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      10. Egypt
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      11. Nigeria
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      12. Rest of MEA
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
    5. LATAM
      1. LATAM Infectious Respiratory Disease Diagnostics Market By Product Type 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Consumables
        3. Services
      2. LATAM Infectious Respiratory Disease Diagnostics Market By Sample Type 2022-2034 (USD MILLION/ Units)
        1. Saliva
        2. Nasopharyngeal Swabs (NPS)
        3. Anterior Nasal Swabs
        4. Blood
        5. Others
      3. LATAM Infectious Respiratory Disease Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Immunoassay
        2. Molecular Diagnostics
        3. Microbiology
        4. Other technologies
      4. LATAM Infectious Respiratory Disease Diagnostics Market By Application 2022-2034 (USD MILLION/ Units)
        1. COVID-19
        2. Influenza
        3. Respiratory Syncytial Virus (RSV)
        4. Tuberculosis
        5. Streptococcus Testing
        6. Other Respiratory Disease Testing
      5. LATAM Infectious Respiratory Disease Diagnostics Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Laboratories
        3. Physician Offices
        4. Other End Users
      6. Brazil
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      7. Mexico
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      8. Argentina
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      9. Chile
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      10. Colombia
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
      11. Rest of LATAM
        1. Instruments
        2. Consumables
        3. Services
        4. Saliva
        5. Nasopharyngeal Swabs (NPS)
        6. Anterior Nasal Swabs
        7. Blood
        8. Others
        9. Immunoassay
        10. Molecular Diagnostics
        11. Microbiology
        12. Other technologies
        13. COVID-19
        14. Influenza
        15. Respiratory Syncytial Virus (RSV)
        16. Tuberculosis
        17. Streptococcus Testing
        18. Other Respiratory Disease Testing
        19. Hospitals
        20. Diagnostic Laboratories
        21. Physician Offices
        22. Other End Users
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.